Feature

Grid Battery Metals: The Right Properties At The Right Time To Serve EV And Battery Metals Surging Demand ($EVKRF)

/ / Feature, Latest

Grid Battery Metals Inc. (OTCQB: EVKRF) is a different kind of nanocap exploration company. In fact, they can claim something that most minerals and metals exploration companies, regardless of size, can’t: being fully funded to advance exploration initiatives throughout its next fiscal year. That’s a rare achievement in a sector where costs can be tremendous. But as valuable to having that advantage is knowing that the investors providing that capital have enough confidence to give millions of dollars upfront to

Grid Battery Metals: The Right Properties At The Right Time To Serve EV And Battery Metals Surging Demand ($EVKRF) Read More »

BYND Cannasoft Positions To Expedite Monetizing Its AI-Empowered EZ-G Sensual Wellness Device ($BCAN)

/ / Feature, Trending

BYND Cannasoft Enterprise (NASDAQ: BCAN) (CSE: BYND) stock may be trading lower, but don’t be misled by the weakness. The microcaps have been getting badly bruised as interest rate hikes and inflation fears continue to weigh on emerging company stocks. That makes sense. But that doesn’t mean that markets don’t overshoot their targets, taking too much value from companies that have full pipelines of potential. That may be the case for BCAN, especially as this company continues to make inroads

BYND Cannasoft Positions To Expedite Monetizing Its AI-Empowered EZ-G Sensual Wellness Device ($BCAN) Read More »

Canopus Biopharma Scores $1 Million Venture Capital Investment, Follows Deal With PepsiCo ($CBIA)

/ / Feature

Canopus Biopharma Inc. (OTC PINK: CBIA) dba Blue Heaven Coffee Inc. (BHC) is changing the unattended retail sector landscape. And based on its announcement Wednesday, there are a million more reasons to appreciate what they’re doing, including in dollar terms. Specifically, CBIA announced receiving a $1,000,000 venture capital investment from a private New York-based office, intended to accelerate CBIA’s (BHC) expansion efforts and secure its place as the leader in providing AI-empowered unattended retail services (vending) in Canada.  That mission is in

Canopus Biopharma Scores $1 Million Venture Capital Investment, Follows Deal With PepsiCo ($CBIA) Read More »

Jiuzi Holdings Focuses On The Underserved China EV And NEV Markets, Targeting Billions In Potential Sales ($JZXN)

/ / Big Stories, Feature

Without a doubt, the electric vehicle (EV) market is red hot. And not only in the United States. It is in China, too, evidenced by Tesla’s (NASDAQ: TSLA) vehicle sales rising 9.3% compared to the same period last year and over 30% from the previous month. Still, the 84,159 cars TSLA sold in August is just a drop in the demand bucket in a market expected to sell tens of millions of EVs in the next few years. That market reality is more than

Jiuzi Holdings Focuses On The Underserved China EV And NEV Markets, Targeting Billions In Potential Sales ($JZXN) Read More »

Mobilicom Stock Has Gained 59% So Far In 2023; Here’s Why This Small-Drone Cybersecurity Company Is Worthy Of Much More ($MOB)

/ / Feature, Most Popular

Mobilicom Limited (NasdaqCM: MOB) stock continues to add to its impressive YTD run, evidenced by a closing price last Friday of $1.55 helping it score an over 59% so far in 2023*. After hours trading added to that sizable increase, with MOB bulls pushing shares another 18% higher to close that session at $1.85. The potentially better news for investors at these levels is that with momentum clearly behind the move, the surge could be the precursor to higher highs.

Mobilicom Stock Has Gained 59% So Far In 2023; Here’s Why This Small-Drone Cybersecurity Company Is Worthy Of Much More ($MOB) Read More »

Phase 3 Trials To Treat PTSD And SAD Send Bionomics Ltd. Sharply Higher ($BNOX)

/ / Feature, Trending

Investors are paying attention to Bionomics Limited (Nasdaq: BNOX) (ASX: BNO). And rightly so, considering the company is on pace to commence two Phase 3 trials to treat critical unmet medical needs. The first to is expected to be for BNOX’s drug candidate to treat Post Traumatic Stress Disorder (PTSD), a logical assumption considering that BNOX announced in August that the last patient visit had been completed in its Phase 2 ATTUNE study, with topline results from Phase 2b expected

Phase 3 Trials To Treat PTSD And SAD Send Bionomics Ltd. Sharply Higher ($BNOX) Read More »

Bionomics Shares In Rally Mode As Investors Take Interest Ahead Of Planned Phase III Trial To Treat PTSD And SAD ($BNOX)

/ / Feature, Most Popular

Bionomics Limited (Nasdaq: BNOX) (ASX: BNO) shares have kicked into rally mode, surging by over 65% since August 22nd to $1.98 on Tuesday. And heading into the final hour of trading on Wednesday, it appears that investors are intent on keeping the stock in the green. Initial liftoff for BNOX shares started in late August when they announced that the last patient visit had been completed in its Phase 2 ATTUNE study in Post-Traumatic Stress Disorder (“PTSD”). Topline results are

Bionomics Shares In Rally Mode As Investors Take Interest Ahead Of Planned Phase III Trial To Treat PTSD And SAD ($BNOX) Read More »

Mobilicom’s Growth Trajectory Steepens As Its Small-Drone Cybersecurity Solutions Earn Global Sales Traction ($MOB)

/ / Feature, Trending

Mobilicom Limited (NasdaqCM: MOB) stock is earning investors’ attention. And rightly so. Its stock is higher by over 50% so far in 2023. While an impressive run, the better news for the company and its investors is that those gains could be the precursor to even higher highs. That may sound like overzealous bullish expectations, but know this about Mobilicom. They are one of the most technically advanced cybersecurity and “smart” solutions providers for small-drones, robotics, and autonomous platforms. As

Mobilicom’s Growth Trajectory Steepens As Its Small-Drone Cybersecurity Solutions Earn Global Sales Traction ($MOB) Read More »

Grid Battery Metals Rally Gains Energy, Over 178% Higher Since June ($EVKRF)

/ / Feature, Trending

Grid Battery Metals Inc. (OTCQB: EVKRF) stock reclaimed its bullish mood, evidenced by its price increase to over $0.103 since last Friday’s close. The potentially better news is that breaching its 52-week highs is a viable near-term target, with the $0.12 level, about 20% higher than the current, in investors’ crosshairs. And keep in mind that the run hasn’t been a short-term phenomenon; this rally has shown some strong legs, which have pushed EVKRF shares higher by over 178% since

Grid Battery Metals Rally Gains Energy, Over 178% Higher Since June ($EVKRF) Read More »

ASP Isotopes Stock Soars 284% Since Inking $9 Million Contract Isotope Supply With US Client ($ASPI)

/ / Feature, Most Popular

ASP Isotopes, Inc. (NasdaqCM: ASPI) stock surged after announcing a $9 million isotope supply contract with its first US customer. At $1.23 today, the gains since June have reached 284%. And that’s taking into account profit taking when prices were higher. ASPI stock touched $1.78 earlier this month, an over 456% increase worthy of taking some gains off the table. The share price increase was and is warranted. As noted, ASPI announced making its US market entrance on a deal

ASP Isotopes Stock Soars 284% Since Inking $9 Million Contract Isotope Supply With US Client ($ASPI) Read More »

CONTACT US
CONTACT US